Slovenia vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy
Slovenia
0 patients
in 2021
Yemen
0 patients
in 2020
Slovenia rank
141st
Yemen rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Slovenia
- Yemen
How they compare
Slovenia currently reports 0 patients against 0 patients in Yemen, a difference of 0 patients.
The two have swapped places 4 times across 9 shared years of data; in 2005 it was Yemen ahead.
Slovenia ranks 141st and Yemen ranks 141st of 183 countries.
Across the 3 decades both report, Slovenia averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Slovenia | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.5 patients | 0 patients | 0.5 patients | Slovenia |
| 2010s | 0.25 patients | 10.5 patients | 10.25 patients | Yemen |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Slovenia or Yemen?
- Slovenia, at 0 patients against 0 patients in Yemen as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Slovenia and Yemen?
- 0 patients, with Slovenia ahead.
- How many years of comparable data are there for Slovenia and Yemen?
- 9 years are reported by both, from 2005 to 2020.
- How do Slovenia and Yemen rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Slovenia ranks 141st and Yemen ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.